Nachrichten zur Apellis Pharmaceuticals Inc. Aktie

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 32.665$

Dunlop, A. Sinclair - Aufsichtsrat - Tag der Transaktion: 2023-03-01...…

Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares

WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical company and leader…

Why Apellis Pharmaceuticals Stock Surged This Week

A highly eventful five days for the company saw bulls pile into its shares....…

Form 8-K Apellis Pharmaceuticals, For: Feb 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals prices $350M in stock offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

WALTHAM, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in…

Thinking about trading options or stock in Wix.Com, Palo Alto Networks, Tesla, Progressive, or Apellis Pharmaceuticals?

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WIX, PANW, TSLA, PGR, and APLS. Click…

Apellis Pharmaceuticals to raise $300M in stock and warrants offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) delivered earnings and revenue surprises of 9.09% and 8.47%, respectively, for the quarter ended December 2022.…

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Thinking about buying stock in Apellis Pharmaceuticals, Vir Biotechnology, Actinium Pharmaceuticals, Arbe Robotics, or Sigma Lithium?

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APLS, VIR, ATNM, ARBE, and SGML. To…

S&P 500 Futures Fall in Premarket Trading; Apellis Pharmaceuticals, Teck Resources Lead

S&P 500 Futures Fall in Premarket Trading; Apellis Pharmaceuticals, Teck Resources Lead...…

Analysts Estimate Apellis Pharmaceuticals, Inc. (APLS) to Report a Decline in Earnings: What to Look Out for

Apellis Pharmaceuticals, Inc. (APLS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

XFRA : 1JK: Wiederaufnahme/Resumption

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…

Stocks to Watch: Apellis Pharmaceuticals, Sigma Lithium

Stocks to Watch: Apellis Pharmaceuticals, Sigma Lithium...…

Apellis Pharmaceuticals Shares Rise 11% on FDA Approval of Syfovre

Apellis Pharmaceuticals Shares Rise 11% on FDA Approval of Syfovre...…

Apellis wins FDA nod for eye disorder therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

XFRA : 1JK: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION - US03753U1060

Instrument ID [10573] (1JK - US03753U1060) suspended...…

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Chief Scientific Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 653.400$

Deschatelets, Pascal - Vorstand - Tag der Transaktion: 2023-02-08...…

Age-related macular degeneration (AMD) market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others - Technavio

NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Technavio report provides the key offerings of 15+ vendors of the age-related macular…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 26.305$

Dunlop, A. Sinclair - Aufsichtsrat - Tag der Transaktion: 2023-02-01...…

Insiderhandel: Chief People Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 152.419$

Lewis, Karen - Vorstand - Tag der Transaktion: 2023-01-23...…

Insiderhandel: Chief Development Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 231.027$

Eisele, Jeffrey - Vorstand - Tag der Transaktion: 2023-01-23...…

Insiderhandel: Chief Scientific Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 552.960$

Deschatelets, Pascal - Vorstand - Tag der Transaktion: 2023-01-09...…

Insiderhandel: Chief Medical Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 121.975$

Grossi, Federico - Vorstand - Tag der Transaktion: 2023-01-05...…

Form 8-K Apellis Pharmaceuticals, For: Jan 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 253.500$

Townsend, Adam J. - Vorstand - Tag der Transaktion: 2023-01-03...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 25.350$

Dunlop, A. Sinclair - Aufsichtsrat - Tag der Transaktion: 2023-01-03...…

Form 8-K Apellis Pharmaceuticals, For: Jan 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Chief Executive Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 1.467.983$

Francois, Cedric - Vorstand - Tag der Transaktion: 2022-12-19...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 65.438$

Machiels, Alec - Aufsichtsrat - Tag der Transaktion: 2022-12-15...…

Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe

Apellis (APLS) submits a marketing authorization application for pegcetacoplan to treat geographic atrophy secondary to age-related macular degeneration to the…

Apellis Submits Marketing Authorization Application to the European Medicines Agency for Pegcetacoplan for Geographic Atrophy

WALTHAM, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and…

Insiderhandel: Chief Scientific Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 570.000$

Deschatelets, Pascal - Vorstand - Tag der Transaktion: 2022-12-08...…

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Apellis Pharmaceuticals, Inc. (APLS) Down 0.5% Since Last Earnings Report: Can It Rebound?

Apellis Pharmaceuticals, Inc. (APLS) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 251.900$

Townsend, Adam J. - Vorstand - Tag der Transaktion: 2022-12-05...…

Premarket Movers: Elbit Systems, CME Group Cl A, Apellis Pharmaceuticals

Premarket Movers: Elbit Systems, CME Group Cl A, Apellis Pharmaceuticals...…

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Apellis (APLS) Rises on FDA Acceptance of NDA Amendment for GA

The FDA accepts Apellis (APLS) major amendment to the NDA for pegcetacoplan to treat geographic atrophy secondary to age-related macular…

Thinking about trading options or stock in Ross Stores, Apellis Pharmaceuticals, Exxon Mobil, Meta Platforms, or Alibaba?

NEW YORK, Nov. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ROST, APLS, XOM, META, and BABA. Click…

dpa-AFX ProFeed